Company Overview and News
The World Cup began in 1930. After a 12-year break due to World War II, the soccer — oops, fútbol — tournament has been played every four years since 1950. This weekend we watched France beat Croatia 4-2 to win the 2018 World Cup. But it got us thinking, what about a World Cup for dividend stocks?
LOW PG PH AWR GPC NYTAB CL JNJ NWN KO DOV EMR MMM
This copy is for your personal non-commercial use only. To order presentation-ready copies of Toronto Star content for distribution to colleagues, clients or customers, or inquire about permissions/licensing, please go to: www.TorontoStarReprints.com
KHC THI KO
The poor are usually defined as those who are below a given level of income that would be insufficient to meet their basic needs. In my view, the poor – no matter whether it is an individual, family or a nation – are those who are unable to read the oncoming information logically, assess the risks posed or opportunities offered to them and take measures to minimise risks or augment prospects. In this sense, we all are poor.
HARARE, July 13 (Reuters) - A European investor’s phone rings in a Harare restaurant and it’s good news: an $80 million construction deal has been agreed with the Zimbabwean government. All that’s needed now is a central bank guarantee letter. It never arrives.
GEC GE KO GNE
HARARE (Reuters) - A European investor’s phone rings in a Harare restaurant and it’s good news: an $80 million construction deal has been agreed with the Zimbabwean government. All that’s needed now is a central bank guarantee letter. It never arrives.
GEC GE KO GNE
Cheyenne, Wyoming, July 12, 2018 (GLOBE NEWSWIRE) -- InCapta, Inc. (OTCQB:INCT), announced that the company is working in conjunction with Royal Fortune Films, a multimedia Production company based in Fort Worth, Texas, as they begin pre-production and principal photography for the football film “4th and Goal.” The film is projected to begin shooting in the 4th Quarter of 2018.
Facebook, Inc. (NASDAQ:FB) has quieted its doubters — at least for now. Facebook stock reached another all-time closing high on Monday, finishing just south of $205. The stock now has gained 15% so far this year — an improvement that seemed unlikely just a few months ago.
WFC WFCNP WFC.WS FB SQ SQNXF WFC.PRL NFLX WFC.PRJ WFC.PRT WFC.PRR WFC.PRQ WFC.PRP WFC.PRO WFC.PRN TWTR KO WFC.PRY WFC.PRX WFC.PRW WFC.PRV SNAP
I was a skeptic toward McDonald’s (NYSE:MCD) for some time. MCD stock took off in late 2015, not long after CEO Steve Easterbrook took over. MCD bulls pointed to strong same-restaurant sales numbers. But I argued through 2016 that the seeming improvement under Easterbrook was coming from easy year-prior comparisons, not necessarily a massive improvement in the business.
LW YUM KO MCD DPZ
M&A activity has been big part of the global market for the past few years now, and that’s likely to continue. Tax reform has freed up more cash and made potential targets more accretive. The economy is humming along. And in a few key sectors — consumer goods and media come to mind — there’s an obvious logic behind consolidation.
TXN GRA TWX MS.PRE MS.PRF MS.PRG MS.PRA WMT WFM ERIC SFM HON AVGO CSCO NOK MS MXIM AA FOX GD SQ LGF HAIN UTX ARNC TWC HRL MAT MS.PRI GOOGL ERI MS.PRK PENN MSFT LVS BA QCOM BB FOXA GCP XLNX LMT MGM FB MTSI PNK RAD CPB PYPL AVAV GOOG FIZZ KR AMCX 6723 KO RNECY MSGN CIEN DIS HON WYNN CMCSA RNECF MA COL BMRN SNY RHT TGT V HAS PEP DPS T ADI KHC LGF.A LGF.B
PepsiCo (NYSE:PEP) beat on both revenue and earnings estimates in their latest earnings report. On that news, PEP stock surged above the $111 per share level. While the company enjoys a track record of exceeding earnings, it has struggled as consumers at home turn away from their core brands. Although PEP stock has resumed its pattern of slow growth, it remains a stock better suited for those in need of dividend income.
50m - Asif
History and Development of the Company Kitov Pharma was incorporated under the laws of the State of Israel (under a previous name) on August 12, 1968 and its ordinary shares were originally listed for trading on the TASE in 1978. The company's ordinary shares are currently traded on the TASE under the symbol “KTOV”, and its ADSs and its public warrants are traded on NASDAQ under the symbols “KTOV” and “KTOVW”, respectively. In October 2012, the District Court in Lod, Israel approved the creditors arrangement in accordance with Section 350 of the Companies Law in order to effectuate the sale by Kitov Pharma (then known as Mainrom Line Logistics Ltd.) of all its activities, assets, rights, obligations and liabilities to a private company held by its then controlling shareholders, and all rights of Kitov Pharma’s creditors against it were extinguished. The sale was made pursuant to an arrangement between Kitov Pharma and its creditors. Following such sale and a related cash...
2h - Asif
Overview and Recent Developments Athersys is an international biotechnology company that is focused primarily in the field of regenerative medicine. The company's MultiStem® cell therapy, a patented and proprietary allogeneic stem cell product, is its lead platform product and is currently in later-stage clinical development. The company's current clinical development programs are focused on treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, certain pulmonary conditions and other conditions where the current standard of care is limited or inadequate for many patients, particularly in the critical care segment. Current Programs By applying its proprietary MultiStem cell therapy product, the company established therapeutic product development programs treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, and other conditions. The company's programs in the clinical development stage include ...
22h - Asif
General The company's objective is to build a profitable and growing specialty therapeutics company. To meet this objective, Cytori Therapeutics has acquired and are developing two technology platforms that hold promise for treating millions of patients and represent significant potential for increasing shareholder value. The company's current corporate activities fall substantially into advancing these platforms: Cytori Nanomedicine and Cytori Cell Therapy. The Cytori Nanomedicine platform features a versatile liposomal nanoparticle technology for drug encapsulation that has thus far provided the foundation to bring two promising drugs into mid/late stage clinical trials. Nanoparticle encapsulation is promising because it can help improve the delivery and metabolism of many drugs, thus potentially enhancing the therapeutic profile and patient benefits. The company's lead drug candidate, ATI-0918 is a generic version of pegylated liposomal encapsulated doxorubicin. Pegyl...
Silicon Investor Message Boards
This table lists all message boards related to KO / Coca Cola Co. on message board site Silicon Investor.
as of ET